Vitreous fluid chemicals in eye diseases
Part of Eyes & vision clinical trials.
This study looks at the chemicals in the fluid inside your eye (vitreous) using a special scan. It aims to find patterns that might help doctors understand certain eye diseases better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have one of these eye conditions: idiopathic macular hole, diabetic retinopathy, retinal detachment, idiopathic macular membrane, or retinal vein occlusion
- Your doctor has recommended a vitrectomy surgery to treat your eye condition
- You have not had a vitrectomy in the past
- You do not have another active eye disease like an infection or inflammation
- You do not have a serious overall health problem like uncontrolled high blood pressure or diabetes
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a robotic system for eye surgery to treat conditions like vitreous hemorrhage or macular pucker. It may help patients who need a procedure called vitrectomy under general anesthesia.
This study looks at how people with severe nonproliferative diabetic retinopathy do after they have vitrectomy (a type of eye surgery). The goal is to better predict prognosis and possibly improve care planning after surgery.
This study collects retina fluid samples from people getting treatment for a vitreoretinal disease. It aims to find better ways to understand and manage these conditions.
This study is building a detailed database of images and information from people with various eye diseases, especially those involving inflammation or swelling. Researchers will use advanced cameras and tests to better understand these conditions and potentially improve treatments.
This Phase 2 trial tests an injection of topotecan into the eye after surgery for retinal detachment that keeps coming back due to scar tissue (proliferative vitreoretinopathy). It may help improve how the retina heals after difficult, repeat operations when vision is usually very guarded.
This trial tests a new medicine, RRG001, given after vitrectomy surgery for severe diabetic eye disease. It aims to see if the drug is safe and helps prevent vision loss.
Hear when a new Vitreoretinal Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.